Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

HIV Infections*/prevention & control ; Sex Workers* ; Sexually Transmitted Diseases*/prevention & control ; Pre-Exposure Prophylaxis*; Pregnancy ; Adolescent ; Female ; Humans ; South Africa ; Contraception

Background: South African women, including female sex workers (FSWs), are disproportionately affected by HIV, experience a high unmet need for contraception and high rates of sexually transmitted infections (STIs). Products that address the interlinked risk between HIV, unplanned pregnancy, and other STIs are needed. There are several multipurpose-prevention technologies (MPTs) in development, aimed at preventing both HIV and pregnancy. This study aimed to explore educational messaging and demand creation channels to improve the potential uptake of a hypothetical MPT implant, using participatory action research. It also aimed to look at product and service provision attributes preferred by potential end users.
Methods: Between July and August 2022, 303 PrEP-eligible adolescent girls and young women (AGYW) (18-24 years), women > 24 years, and FSW's (≥ 18 years) participated in 4-hour workshops, where they were asked about their ideal messaging and demand creation channels and their preferences for different attributes of an MPT implant. Quantitative descriptive analysis was conducted to determine the frequency and ranking for each demand creation message, channel, and each product and service provision attribute, by population group. A chi-square test was used to assess MPT implant characteristics associated with age. Qualitative data were analysed using deductive and thematic analysis.
Results: A total of 104 AGYW, 157 women > 24 years, and 42 FSWs participated in the PAR workshops. Participants preferred demand creation messages that were empowering, motivational and encouraged body autonomy. The use of slang was popular. Community radio stations and newspapers, social media, and information at hospitals and clinics were participants' preferred MPT demand creation channels because they were easily accessible. Providing long-term and dual HIV and pregnancy protection, receiving implant services at the local clinic, manageable side effects, discreet and private implant, and numbing the area before insertion and removal, were the most preferred product and service provision attributes.
Conclusion: Early considerations for women's product preferences are key to product development. Educational messaging around the MPT implant should be empowering and in local languages, this may motivate women to learn more about it and use it. Multiple demand creation channels should be used to engage both young and older populations, which may ensure better reach.
(© 2023. BioMed Central Ltd., part of Springer Nature.)

World J AIDS. 2015 Mar;5(2):10-20. (PMID: 26767149)
PLoS One. 2013 Aug 26;8(8):e66593. (PMID: 23990868)
Front Reprod Health. 2021 Jul 14;3:684114. (PMID: 36304059)
PLoS Curr. 2015 Apr 08;7:. (PMID: 25914860)
Front Reprod Health. 2022 Dec 05;4:1048702. (PMID: 36545490)
BMC Public Health. 2018 Jan 26;18(1):183. (PMID: 29373958)
Wellcome Open Res. 2019 Dec 12;4:200. (PMID: 31950089)
J Int AIDS Soc. 2020 Jun;23(6):e25528. (PMID: 32544303)
Perspect Sex Reprod Health. 2010 Sep;42(3):160-7. (PMID: 20887285)
Sex Reprod Health Matters. 2021 Dec;29(1):1927477. (PMID: 34224341)
Child Indic Res. 2022;15(4):1269-1293. (PMID: 35079296)
PLoS One. 2021 Oct 14;16(10):e0258542. (PMID: 34648589)
Sci Rep. 2021 Dec 9;11(1):23740. (PMID: 34887462)
J Int AIDS Soc. 2018 Mar;21(3):. (PMID: 29537654)
BJOG. 2014 Oct;121 Suppl 5:27-34. (PMID: 25335838)
S Afr Med J. 2016 Dec 01;106(12):1151-1153. (PMID: 27917757)
PLoS One. 2016 Aug 15;11(8):e0159162. (PMID: 27526116)
Int J Sex Health. 2021 Jan 25;33(1):40-57. (PMID: 38596471)
Sex Health. 2018 Nov;15(6):570-577. (PMID: 30408430)
BMC Public Health. 2006 May 03;6:123. (PMID: 16672067)
AIDS Res Ther. 2021 Nov 20;18(1):88. (PMID: 34801037)
J Med Internet Res. 2015 Nov 02;17(11):e248. (PMID: 26525289)
J Med Internet Res. 2021 Jan 20;23(1):e17187. (PMID: 33470931)
AIDS Behav. 2022 Sep;26(9):2907-2919. (PMID: 35247114)
PLoS Med. 2018 Feb 27;15(2):e1002511. (PMID: 29485986)
PLoS Med. 2018 Feb 27;15(2):e1002512. (PMID: 29485985)
Glob Health Action. 2021 Jan 1;14(1):1953243. (PMID: 34338167)
Front Reprod Health. 2021 Sep 06;3:704841. (PMID: 36304018)
Emerg Themes Epidemiol. 2021 Mar 12;18(1):3. (PMID: 33706776)
J Int AIDS Soc. 2018 Aug;21(8):e25170. (PMID: 30152004)
Stud Fam Plann. 2020 Jun;51(2):161-176. (PMID: 32358789)
PLOS Glob Public Health. 2022 Oct 3;2(10):e0000762. (PMID: 36962565)
Health Promot Chronic Dis Prev Can. 2016 Apr;36(4):63-75. (PMID: 27077792)
BMC Public Health. 2022 May 14;22(1):973. (PMID: 35568839)
AIDS Behav. 2018 Aug;22(8):2662-2673. (PMID: 29560570)
Am J Public Health. 2013 Jan;103(1):e9-18. (PMID: 23153164)
Gates Open Res. 2020 Mar 10;4:29. (PMID: 32411946)
J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):350-356. (PMID: 31904708)
Lancet. 2010 Jul 3;376(9734):41-8. (PMID: 20557928)
AIDS Patient Care STDS. 2019 Apr;33(4):157-166. (PMID: 30932697)
AIDS. 2019 Jan 27;33(1):83-91. (PMID: 30289813)
BJOG. 2014 Oct;121 Suppl 5:45-52. (PMID: 25335840)

INV-022667 United States GATES Bill & Melinda Gates Foundation

Keywords: Contraception; Demand creation; HIV prevention; Multipurpose-prevention technology; South Africa; Women

Date Created: 20231025 Date Completed: 20231027 Latest Revision: 20241013

20241013

PMC10598950

10.1186/s12889-023-16904-0

37880628